SCHEMBL21687993

SCHEMBL21687993

N#Cc1ccc2c(c1)c1cc(C#N)ccc1n2-c1ccc(-c2cccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3C#N)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A3 P47895 1/20 0.33
RARG P13631 1/20 0.32
PGR P06401 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
TDP2 O95551 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
KAT6A Q92794 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21688034 0.97 KDM4E (0.33) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687990 0.94 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687470 0.93 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687994 0.92 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21688166 0.91 KDM4E (0.35) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21688024 0.90 ALDH1A3 (0.37) ALDH1A3RARGPGRPIK3CDPIK3CA
SCHEMBL21687500 0.90 KDM4E (0.33) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21688090 0.89 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21688085 0.89 KDM4E (0.38) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687693 0.89 PGR (0.34) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885ALDH1A1 616/4885LMNA 1582/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885ALDH1A1 616/4885LMNA 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.